Not worried about capacity addition in chemicals, FDA red flags in pharma: Kenneth Andrade

Andrade agrees that peak profitability may be behind, and that competition is expected to increase. And yet, there could be an opportunity for Indian chemical companies because of the changed priorities for governments and corporates post-pandemic

Related Keywords

China ,India ,Kenneth Andrade ,V Anantha Nageswaran , ,Chief Investment Officer ,Old Bridge Capital ,Economic Advisorv Anantha Nageswaran ,Us Fda Red Flags In Pharma ,Old Bridge Capital Management ,Hemical Companies Shares ,